Skip to Main Content

Paper Details

Accounting for proximal variants improves neoantigen prediction.
Nat Genet
33
2019
cancer, major histocompatibility complex class I neoantigen peptides, neoantigenic peptide, proximal variants, tumors
Author NameAffiliation
Jasreet HundalMcDonnell Genome Institute, Washington University School of Medicine
Susanna KiwalaMcDonnell Genome Institute, Washington University School of Medicine
Yang-Yang FengMcDonnell Genome Institute, Washington University School of Medicine
Connor J LiuMcDonnell Genome Institute, Washington University School of Medicine
Ramaswamy GovindanSiteman Cancer Center, Washington University School of Medicine
Ramaswamy GovindanWashington University School of Medicine
Ravindra UppaluriBrigham and Women's Hospital and Dana-Farber Cancer Institute
Sanjay J SwamidassWashington University School of Medicine
Obi L GriffithMcDonnell Genome Institute, Washington University School of Medicine
Obi L GriffithSiteman Cancer Center, Washington University School of Medicine
Obi L GriffithWashington University School of Medicine
Obi L GriffithWashington University School of Medicine
Elaine R MardisInstitute for Genomic Medicine, Nationwide Children's Hospital
Elaine R MardisInstitute for Genomic Medicine, Nationwide Children's Hospital
Malachi GriffithMcDonnell Genome Institute, Washington University School of Medicine
Malachi GriffithSiteman Cancer Center, Washington University School of Medicine
Malachi GriffithWashington University School of Medicine
Malachi GriffithWashington University School of Medicine
  • 1 - 18

Datasets